Molecular Cardiology and Hypertension

Molecular cardiology could be a new space of cardiovascular drugs that aims to use molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of heart failure As an rising discipline, it's modified our abstract thinking of cardiovascular development, sickness etiology, and pathophysiology. Although molecular cardiology continues to be at a awfully early stage, it's opened a promising avenue for understanding and dominant upset. A great interest of the laboratory is that the identification of novel current factors that regulate cardiac biology, as well as aging and hypertrophy.

Hypertension is that the single most vital risk issue for stroke. It causes about 50 per cent of ischemic strokes and also increases the risk of hemorrhagic stroke. The injury that high blood pressure causes happens over time and is commonly solely diagnosed once wide injury has already happened to the body’s blood vessels. The increase in vessel risk has primarily been delineated  in terms of elevated blood pressure in those over age sixty years and elevation in blood pressure in younger people.

    Related Conference of Molecular Cardiology and Hypertension

    October 06-07, 2025

    6th International Conference on Physics

    Paris, France
    December 01-02, 2025

    9th International Meeting on Fluid Dynamics & Fluid Mechanics

    Vancouver, Canada
    December 15-16, 2025

    13th World Congress on Physical and Theoretical Chemistry

    Amsterdam, Netherlands
    February 09-10, 2026

    9th World Congress On Cardiology and Heart Failure

    London, UK

    Molecular Cardiology and Hypertension Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in